R. Jacob Vogelstein is co-founder and managing partner of Catalio Capital Management, investing in innovative private healthcare companies. He previously invested in biomedical technology at Camden Partners and served on the faculty of Johns Hopkins University’s Applied Physics Laboratory and Whiting School of Engineering.

Unclaimed profile

R. Jacob Vogelstein is co-founder and managing partner of Catalio Capital Management, investing in innovative private healthcare companies. He previously invested in biomedical technology at Camden Partners and served on the faculty of Johns Hopkins University’s Applied Physics Laboratory and Whiting School of Engineering.

Career

R. Jacob Vogelstein holds a BSc, Bio-Electrical Engineering from Brown University and a PhD, Biomedical Engineering from Johns Hopkins University School of Medicine.

Co-Founder & Managing Partner at Catalio Capital Management until Present
Board Member at Iambic Therapeutics until Present
Board Member at Rhapsogen until Present
Board Member at Syndeio until Present
Board Member at Clasp Therapeutics until Present
Board Member at Nextpoint Therapeutics until Present
Board Member at Pheast Therapeutics until Present
Board Member at Winnow Therapeutics until Present

Cosigns Received

Thomas Macrina
First Cosign
@IARPAnews, @DavidAMarkowitz, & @RJVogelstein deserve a lot of credit for how they structured the MICrONS program – it really stretched us.
Source

R.'s Collections

R.'s Lists

In these lists

Cosigns Given